Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and Beyond
Sustained weight loss may contribute to improvements in: blood sugar control blood pressure cholesterol levels joint health sleep quality For some individuals, these improvements may reduce the need for other medications or medical treatments
It is biology doing what biology does, which is defending a set point through a tangle of overlapping appetite signals
Semaglutide, combined with diet and exercise, helps many people maintain healthier blood sugar levels
People on tirzepatide were also more likely than those on semaglutide to lose at least 10%, 15%, 20%, or 25% of their body weight
For most people who are good candidates for GLP-1 therapy, starting now with tirzepatide and potentially transitioning to retatrutide after approval is a smarter play than waiting 18-24 months